Masimo Says Users Are Better Off Without Apple’s Oxygen Tool (1)

Jan. 18, 2024, 10:23 PM UTC

Masimo Corp. Chief Executive Officer Joe Kiani, waging a legal fight with Apple Inc. over a blood oxygen feature, said that consumers are better off without the iPhone maker’s version of the technology.

The remarks followed Apple’s decision to cease sales of smartwatches Thursday that had the tool — a gauge of blood oxygen saturation known as a pulse oximeter — which had been a heavily marketed health feature on the devices. The move stemmed from a ruling by the US International Trade Commission that found the technology violated Masimo patents.

Customers should buy pulse oximeters from Masimo or ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.